Bioporto A/S
CSE:BIOPOR

Watchlist Manager
Bioporto A/S Logo
Bioporto A/S
CSE:BIOPOR
Watchlist
Price: 1.482 DKK -0.13% Market Closed
Market Cap: 636.8m DKK
Have any thoughts about
Bioporto A/S?
Write Note

Relative Value

The Relative Value of one BIOPOR stock under the Base Case scenario is 1.301 DKK. Compared to the current market price of 1.482 DKK, Bioporto A/S is Overvalued by 12%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIOPOR Relative Value
Base Case
1.301 DKK
Overvaluation 12%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
47
vs Industry
27
Median 3Y
20.1
Median 5Y
21.4
Industry
7.6
Forward
15.8
vs History
vs Industry
Median 3Y
-10.3
Median 5Y
-10.2
Industry
22.1
Forward
-8.2
vs History
vs Industry
Median 3Y
-10.2
Median 5Y
-10.3
Industry
21.9
vs History
vs Industry
Median 3Y
-9.5
Median 5Y
-9.7
Industry
23.4
vs History
80
vs Industry
3
Median 3Y
9
Median 5Y
11.1
Industry
2.5
vs History
55
vs Industry
24
Median 3Y
18.4
Median 5Y
20.3
Industry
7.5
Forward
13.3
vs History
60
vs Industry
15
Median 3Y
27.5
Median 5Y
31
Industry
9.3
vs History
vs Industry
Median 3Y
-9.5
Median 5Y
-9.3
Industry
4.2
vs History
vs Industry
Median 3Y
-8.9
Median 5Y
-8.9
Industry
4
Forward
-6.6
vs History
vs Industry
Median 3Y
-9.7
Median 5Y
-10
Industry
5.9
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-9.8
Industry
3.9
vs History
25
vs Industry
6
Median 3Y
23.1
Median 5Y
23.6
Industry
4.5

Multiples Across Competitors

BIOPOR Competitors Multiples
Bioporto A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Bioporto A/S
CSE:BIOPOR
636.8m DKK 18.8 -12.7 -9.7 -9.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 027 714.7 -180 740.1 -219 476 -216 971.5
US
Abbvie Inc
NYSE:ABBV
310.2B USD 5.6 61 15.2 23.4
US
Amgen Inc
NASDAQ:AMGN
142B USD 4.4 33.4 16.1 30.5
US
Gilead Sciences Inc
NASDAQ:GILD
115B USD 4.1 910 10.1 10.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
101.6B USD 9.5 -211.2 20.8 21.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 852.6 -472.7 -514.8 -501.1
AU
CSL Ltd
ASX:CSL
134.4B AUD 5.7 31.8 19.7 24.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD 5.6 16.8 15.3 17
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.8 -53
NL
argenx SE
XBRU:ARGX
36B EUR 19.3 -135.6 -109.5 -79.8
P/S Multiple
Revenue Growth P/S to Growth
DK
Bioporto A/S
CSE:BIOPOR
Average P/S: 3 457 241.6
18.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
38 027 714.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.5
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.3
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
DK
Bioporto A/S
CSE:BIOPOR
Average P/E: 210.6
Negative Multiple: -12.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 740.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.4
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
910
77%
11.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -211.2
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.7 N/A N/A
AU
CSL Ltd
ASX:CSL
31.8
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -135.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
Bioporto A/S
CSE:BIOPOR
Average EV/EBITDA: 16.2
Negative Multiple: -9.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 476 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16.1
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
20.8
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.8 N/A N/A
AU
CSL Ltd
ASX:CSL
19.7
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.3
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.8 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -109.5 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
Bioporto A/S
CSE:BIOPOR
Average EV/EBIT: 21.3
Negative Multiple: -9.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 971.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.5
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.9
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.1 N/A N/A
AU
CSL Ltd
ASX:CSL
24.6
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -79.8 N/A N/A

See Also

Discover More
Back to Top